GSK3 inhibition ameliorates the abnormal contractility of Newfoundland ACM patient iPSC-cardiomyocytes
American Journal of Physiology-Cell Physiology · 2025
DOI: 10.1152/ajpcell.01025.2024 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2025. Verfasst von Rebecca J Noort und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biomedical Sciences, Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Myocytes, Cardiac, Myocardial Contraction, Cardiomyopathies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Stem Cell Network (SCN), Canadian Government | Canadian Institutes of Health Research (CIHR).
Abstract (Originalsprache)
This is the first characterization of induced pluripotent stem cell-cardiomyocytes (iPSC-CMs) from Newfoundland patients with ACM. We find that ACM iPSC-CMs exhibit extreme proarrhythmic tendencies that can be normalized with GSK3 inhibition. Importantly, GSK3 inhibition is accompanied by a significant increase in key proteins, such as β-catenin and Lamin A/C, pointing toward a possible mechanism both for disease pathogenesis and therapy via GSK3 inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Biomedical Sciences, Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada.
- Discipline of Surgery, Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada.
- Division of Population Health and Applied Health Sciences, Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada.
ORCID-Profile: Rebecca J Noort, Kathleen A Hodgkinson, Jessica L Esseltine
Förderung
- Stem Cell Network (SCN)
- Canadian Government | Canadian Institutes of Health Research (CIHR)
Zitieren
APA
Noort, R. J., Salman, W., Fuchs, C., Braun, U., Pace, D., Hodgkinson, K. A., & Esseltine, J. L. (2025). GSK3 inhibition ameliorates the abnormal contractility of Newfoundland ACM patient iPSC-cardiomyocytes. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.01025.2024
Vancouver
Noort RJ, Salman W, Fuchs C, Braun U, Pace D, Hodgkinson KA, et al. GSK3 inhibition ameliorates the abnormal contractility of Newfoundland ACM patient iPSC-cardiomyocytes. American Journal of Physiology-Cell Physiology. 2025. doi:10.1152/ajpcell.01025.2024
BibTeX
@article{Noort2025,
author = {Noort, Rebecca J and Salman, Wesam and Fuchs, Camila and Braun, Ursula and Pace, David and Hodgkinson, Kathleen A and Esseltine, Jessica L},
title = {GSK3 inhibition ameliorates the abnormal contractility of Newfoundland ACM patient iPSC-cardiomyocytes},
journal = {American Journal of Physiology-Cell Physiology},
year = {2025},
doi = {10.1152/ajpcell.01025.2024}
}
EUVIMED